OUTLOOK THERAPEUTICS INC (OTLK)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $100.54M
Last updated: Nov 17, 2026 at 11:05 AM ET
OUTLOOK THERAPEUTICS INC (OTLK) Competitors
The companies most similar to OUTLOOK THERAPEUTICS INC are Compass Therapeutics (CMPX), OKYO Pharma (OKYO) and Pmv Pharmaceuticals (PMVP). By market cap, OUTLOOK THERAPEUTICS INC ranks 7th of the 13 companies on this page; Invivyd (IVVD) is the largest at $171.58M.
Peer Comparison
OTLK's revenue growth of -99.4% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| OUTLOOK THERAPEUTICS INC (OTLK) | $100.54M | N/A | N/A | 0.0% | -776.9% | -99.4% | 0.00% |
| Compass Therapeutics Inc. (CMPX) | $139.35M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| OKYO Pharma Limited (OKYO) | $70.85M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Pmv Pharmaceuticals Inc (PMVP) | $95.93M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| NeOnc Technologies Holdings, Inc. Common Stock (NTHI) | $141.66M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Immunic Inc (IMUX) | $102.61M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| XBiotech Inc (XBIT) | $59.76M | N/A | N/A | 0.0% | N/A | -93.3% | 0.00% |
| Neumora Therapeutics, Inc. (NMRA) | $80.59M | N/A | N/A | 0.0% | -260.5% | 0.0% | 0.00% |
| Voyager Therapeutics Inc (VYGR) | $107.66M | N/A | 4.0x | 0.0% | N/A | -70.0% | 0.00% |
| Coya Therapeutics, Inc. Common Stock (COYA) | $73.42M | N/A | 15.0x | 0.0% | N/A | -93.4% | 0.00% |
| vTv Therapeutics Inc (VTVT) | $78.99M | N/A | N/A | -20.8% | N/A | 0.0% | 0.00% |
| OnKure Therapeutics, Inc. (OKUR) | $108.33M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Invivyd Inc. (IVVD) | $171.58M | N/A | 2.9x | -183.9% | N/A | 21.2% | 0.00% |
| Peer median | $99.27M | N/A | 4.0x | 0.0% | -260.5% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to OUTLOOK THERAPEUTICS INC, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Compass Therapeutics Inc. (CMPX) | Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapies to treat multiple... | CMPX competitors |
| OKYO Pharma Limited (OKYO) | OKYO Pharma Limited, a preclinical biopharmaceutical company, is engaged in developing therapies for patients suffering from inflammatory eye diseases and eye... | |
| Pmv Pharmaceuticals Inc (PMVP) | PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53... | PMVP competitors |
| NeOnc Technologies Holdings, Inc. Common Stock (NTHI) | NeOnc Technologies Holdings, Inc. is a pioneering biotechnology firm dedicated to revolutionizing cancer treatment through its advanced immunotherapy... | NTHI competitors |
| Immunic Inc (IMUX) | Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune... | IMUX competitors |
| XBiotech Inc (XBIT) | XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases. | XBIT competitors |
| Neumora Therapeutics, Inc. (NMRA) | Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases... | NMRA competitors |
| Voyager Therapeutics Inc (VYGR) | Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases. | VYGR competitors |
| Coya Therapeutics, Inc. Common Stock (COYA) | Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). | COYA competitors |
| vTv Therapeutics Inc (VTVT) | vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops and sells candidates for orally administered small molecule drugs to meet... | VTVT competitors |
| OnKure Therapeutics, Inc. (OKUR) | OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer. | OKUR competitors |
| Invivyd Inc. (IVVD) | Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery... | IVVD competitors |
Frequently Asked Questions About OTLK
Who are OUTLOOK THERAPEUTICS INC's main competitors?
The companies most similar to OUTLOOK THERAPEUTICS INC include Compass Therapeutics (CMPX), OKYO Pharma (OKYO), Pmv Pharmaceuticals (PMVP), NeOnc Technologies Holdings, Inc. Common Stock (NTHI) and Immunic (IMUX), listed from the closest match.
Who is OUTLOOK THERAPEUTICS INC's biggest competitor?
Invivyd (IVVD) is the largest of the similar companies at $171.58M; Compass Therapeutics (CMPX) is the closest match by business profile, size, sector and industry.
How does OTLK stock compare with its competitors?
OTLK's net margin is 0.0% against a peer median of 0.0%.
Which of OUTLOOK THERAPEUTICS INC's competitors pays a higher dividend?
OUTLOOK THERAPEUTICS INC pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is OUTLOOK THERAPEUTICS INC bigger than its competitors?
No. OUTLOOK THERAPEUTICS INC is 7th by market cap among the 13 companies on this page; the largest is Invivyd (IVVD) at $171.58M.
OTLK pages: Overview, Earnings, Forecast, Financials, Competitors